230 related articles for article (PubMed ID: 30172469)
1. A new severe mutation in the SLC5A7 gene related to congenital myasthenic syndrome type 20.
Pardal-Fernández JM; Carrascosa-Romero MC; Álvarez S; Medina-Monzón MC; Caamaño MB; de Cabo C
Neuromuscul Disord; 2018 Oct; 28(10):881-884. PubMed ID: 30172469
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of a family affected by congenital myasthenic syndrome due to a Novel mutation in the SLC5A7 gene.
Tian S; Sun H; Gao FF; Zhang K; Nan J; Niu M; Jia X; Xu G; Ge W
BMC Neurol; 2024 Jun; 24(1):206. PubMed ID: 38886633
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic congenital myasthenic syndrome due to three novel mutations in SLC5A7 encoding the sodium-dependant high-affinity choline transporter.
Rodríguez Cruz PM; Hughes I; Manzur A; Munot P; Ramdas S; Wright R; Breen C; Pitt M; Pagnamenta AT; Taylor JC; Palace J; Beeson D
Neuromuscul Disord; 2021 Jan; 31(1):21-28. PubMed ID: 33250374
[TBL] [Abstract][Full Text] [Related]
4. The novel p.Ser263Phe mutation in the human high-affinity choline transporter 1 (CHT1/SLC5A7) causes a lethal form of fetal akinesia syndrome.
Banerjee M; Arutyunov D; Brandwein D; Janetzki-Flatt C; Kolski H; Hume S; Leonard NJ; Watt J; Lacson A; Baradi M; Leslie EM; Cordat E; Caluseriu O
Hum Mutat; 2019 Oct; 40(10):1676-1683. PubMed ID: 31299140
[TBL] [Abstract][Full Text] [Related]
5. Congenital myasthenic syndromes.
Hantaï D; Richard P; Koenig J; Eymard B
Curr Opin Neurol; 2004 Oct; 17(5):539-51. PubMed ID: 15367858
[TBL] [Abstract][Full Text] [Related]
6. Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea.
Bauché S; O'Regan S; Azuma Y; Laffargue F; McMacken G; Sternberg D; Brochier G; Buon C; Bouzidi N; Topf A; Lacène E; Remerand G; Beaufrere AM; Pebrel-Richard C; Thevenon J; El Chehadeh-Djebbar S; Faivre L; Duffourd Y; Ricci F; Mongini T; Fiorillo C; Astrea G; Burloiu CM; Butoianu N; Sandu C; Servais L; Bonne G; Nelson I; Desguerre I; Nougues MC; Bœuf B; Romero N; Laporte J; Boland A; Lechner D; Deleuze JF; Fontaine B; Strochlic L; Lochmuller H; Eymard B; Mayer M; Nicole S
Am J Hum Genet; 2016 Sep; 99(3):753-761. PubMed ID: 27569547
[TBL] [Abstract][Full Text] [Related]
7. Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization.
Wang H; Salter CG; Refai O; Hardy H; Barwick KES; Akpulat U; Kvarnung M; Chioza BA; Harlalka G; Taylan F; Sejersen T; Wright J; Zimmerman HH; Karakaya M; Stüve B; Weis J; Schara U; Russell MA; Abdul-Rahman OA; Chilton J; Blakely RD; Baple EL; Cirak S; Crosby AH
Brain; 2017 Nov; 140(11):2838-2850. PubMed ID: 29088354
[TBL] [Abstract][Full Text] [Related]
8. Congenital Myasthenic Syndromes.
Iyadurai SJP
Neurol Clin; 2020 Aug; 38(3):541-552. PubMed ID: 32703467
[TBL] [Abstract][Full Text] [Related]
9. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
[TBL] [Abstract][Full Text] [Related]
10. A new patient with congenital myasthenic syndrome type 20 due to compound heterozygous missense SLC5A7 variants suggests trends in genotype-phenotype correlation.
Vlckova M; Prchalova D; Zimmermann P; Haberlova J; Bendova S; Moslerova V; Stranecky V; Sedlacek Z; Hancarova M
Mol Genet Genomic Med; 2023 Jun; 11(6):e2154. PubMed ID: 36840359
[TBL] [Abstract][Full Text] [Related]
11. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
[TBL] [Abstract][Full Text] [Related]
12. Congenital myasthenic syndrome type 19 due to a novel mutation in the COL13A1 GENE.
Marquardt RJ; Li Y
Muscle Nerve; 2019 Jul; 60(1):E3-E4. PubMed ID: 31018245
[No Abstract] [Full Text] [Related]
13. Temporary diazepam responsive apneic attacks and congenital myasthenic syndrome.
Yis U; Kurul SH; Oztura I; Ozden O; Akinci G; Dirik E
J Child Neurol; 2009 Jul; 24(7):895-8. PubMed ID: 19289695
[TBL] [Abstract][Full Text] [Related]
14. Congenital myasthenic syndromes: an update.
Finlayson S; Beeson D; Palace J
Pract Neurol; 2013 Apr; 13(2):80-91. PubMed ID: 23468559
[No Abstract] [Full Text] [Related]
15. Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations.
Maselli RA; Wei DT; Hodgson TS; Sampson JB; Vazquez J; Smith HL; Pytel P; Ferns M
Muscle Nerve; 2021 Aug; 64(2):219-224. PubMed ID: 34037996
[TBL] [Abstract][Full Text] [Related]
16. Congenital myasthenic syndromes.
Eymard B; Hantaï D; Estournet B
Handb Clin Neurol; 2013; 113():1469-80. PubMed ID: 23622369
[TBL] [Abstract][Full Text] [Related]
17. Congenital myasthenic syndrome due to choline acetyltransferase mutations in infants: clinical suspicion and comprehensive electrophysiological assessment are important for early diagnosis.
Dilena R; Abicht A; Sergi P; Comi GP; Di Fonzo A; Chidini G; Natacci F; Barbieri S; Lochmüller H
J Child Neurol; 2014 Mar; 29(3):389-93. PubMed ID: 23292760
[TBL] [Abstract][Full Text] [Related]
18. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
Tsao CY
Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Genetic Features of Congenital Myasthenic Syndromes due to CHAT Mutations: Case Report and Literature Review.
Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
Neuropediatrics; 2018 Aug; 49(4):283-288. PubMed ID: 29783273
[TBL] [Abstract][Full Text] [Related]
20. Congenital myasthenic syndrome due to a novel missense mutation in the gene encoding choline acetyltransferase.
Schmidt C; Abicht A; Krampfl K; Voss W; Stucka R; Mildner G; Petrova S; Schara U; Mortier W; Bufler J; Huebner A; Lochmüller H
Neuromuscul Disord; 2003 Mar; 13(3):245-51. PubMed ID: 12609506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
